Axa
CDXS icon

Axa’s Codexis CDXS Stock Holding History

Axa’s Portfolio CDXS Stock Details CDXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-22,400
Closed -$374K – 1319
2018
Q4 		$374K Hold
22,400
– – ﹤0.01% 1140
2018
Q3 		$384K Buy
+22,400
New +$362K ﹤0.01% 1190
2017
Q4 		– Sell
-30,300
Closed -$201K – 1351
2017
Q3 		$201K Sell
30,300
-87,470
-74% -$484K ﹤0.01% 1266
2017
Q2 		$642K Hold
117,770
– – ﹤0.01% 1017
2017
Q1 		$565K Hold
117,770
– – ﹤0.01% 1052
2016
Q4 		$542K Sell
117,770
-35,431
-23% -$166K ﹤0.01% 1035
2016
Q3 		$680K Buy
153,201
+47,526
+45% +$200K ﹤0.01% 961
2016
Q2 		$426K Buy
105,675
+40,623
+62% +$149K ﹤0.01% 1039
2016
Q1 		$202K Sell
65,052
-98,618
-60% -$380K ﹤0.01% 1145
2015
Q4 		$692K Buy
163,670
+11,100
+7% +$40.6K ﹤0.01% 976
2015
Q3 		$517K Buy
152,570
+62,645
+70% +$234K ﹤0.01% 1041
2015
Q2 		$350K Buy
89,925
+79,225
+740% +$350K ﹤0.01% 1145
2015
Q1 		$49K Buy
+10,700
New +$37.7K ﹤0.01% 1364
2013
Q3 		– Sell
-29,800
Closed -$66K – 1287
2013
Q2 		$66K Buy
+29,800
New +$67.3K ﹤0.01% 1180

Other funds holding CDXS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Axa's CDXS Position: Q1 2019 in Review

Axa sold out of Codexis (CDXS) in Q1 2019, closing a stake of 22,400 shares — an estimated $374K sold.

Axa first reported a position in CDXS in Q2 2013 and held it in 14 quarters. The position peaked at $692K in Q4 2015. 123 funds tracked by Wall St. Rank hold CDXS as of Q1 2019.

  • Axa reported no remaining Codexis position as of Q1 2019 after selling out during the quarter.
  • Axa sold 22,400 Codexis shares in Q1 2019, an estimated $374K.
  • Axa first reported a position in Codexis in Q2 2013 and held it in 14 quarters.
  • Axa's Codexis position peaked at $692K in Q4 2015.
  • 123 funds tracked by Wall St. Rank held Codexis as of Q1 2019.

Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.